🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.25
-0.35 (-1.18%)
Nov 20, 2026, 1:30 PM CST

Taiyen Biotech Statistics

Total Valuation

Taiyen Biotech has a market cap or net worth of TWD 5.85 billion. The enterprise value is 4.21 billion.

Market Cap5.85B
Enterprise Value 4.21B

Important Dates

The next estimated earnings date is Tuesday, March 9, 2027.

Earnings Date Mar 9, 2027
Ex-Dividend Date Aug 24, 2026

Share Statistics

Taiyen Biotech has 200.00 million shares outstanding. The number of shares has decreased by -0.39% in one year.

Current Share Class 200.00M
Shares Outstanding 200.00M
Shares Change (YoY) -0.39%
Shares Change (QoQ) -0.81%
Owned by Insiders (%) 0.97%
Owned by Institutions (%) 4.40%
Float 91.92M

Valuation Ratios

The trailing PE ratio is 15.55.

PE Ratio 15.55
Forward PE n/a
PS Ratio 1.83
PB Ratio 0.86
P/TBV Ratio 0.87
P/FCF Ratio 17.65
P/OCF Ratio 10.32
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.20, with an EV/FCF ratio of 12.70.

EV / Earnings 11.17
EV / Sales 1.32
EV / EBITDA 6.20
EV / EBIT 10.11
EV / FCF 12.70

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.02.

Current Ratio 2.94
Quick Ratio 2.40
Debt / Equity 0.02
Debt / EBITDA 0.16
Debt / FCF 0.32
Interest Coverage 88.53

Financial Efficiency

Return on equity (ROE) is 5.62% and return on invested capital (ROIC) is 6.67%.

Return on Equity (ROE) 5.62%
Return on Assets (ROA) 4.60%
Return on Invested Capital (ROIC) 6.67%
Return on Capital Employed (ROCE) 5.73%
Weighted Average Cost of Capital (WACC) 4.95%
Revenue Per Employee 7.11M
Profits Per Employee 837,247
Employee Count 450
Asset Turnover 0.39
Inventory Turnover 4.80

Taxes

In the past 12 months, Taiyen Biotech has paid 83.06 million in taxes.

Income Tax 83.06M
Effective Tax Rate 18.06%

Stock Price Statistics

The stock price has decreased by -7.29% in the last 52 weeks. The beta is 0.13, so Taiyen Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.13
52-Week Price Change -7.29%
50-Day Moving Average 30.07
200-Day Moving Average 31.30
Relative Strength Index (RSI) 22.70
Average Volume (20 Days) 194,847

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Taiyen Biotech had revenue of TWD 3.20 billion and earned 376.76 million in profits. Earnings per share was 1.88.

Revenue3.20B
Gross Profit 1.23B
Operating Income 416.34M
Pretax Income 459.82M
Net Income 376.76M
EBITDA 669.59M
EBIT 416.34M
Earnings Per Share (EPS) 1.88
Full Income Statement

Balance Sheet

The company has 1.75 billion in cash and 106.80 million in debt, with a net cash position of 1.64 billion or 8.20 per share.

Cash & Cash Equivalents 1.75B
Total Debt 106.80M
Net Cash 1.64B
Net Cash Per Share 8.20
Equity (Book Value) 6.77B
Book Value Per Share 34.08
Working Capital 1.77B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 566.96 million and capital expenditures -235.46 million, giving a free cash flow of 331.50 million.

Operating Cash Flow 566.96M
Capital Expenditures -235.46M
Depreciation & Amortization 253.25M
Net Borrowing -27.52M
Free Cash Flow 331.50M
FCF Per Share 1.66
Full Cash Flow Statement

Margins

Gross margin is 38.48%, with operating and profit margins of 13.01% and 11.77%.

Gross Margin 38.48%
Operating Margin 13.01%
Pretax Margin 14.37%
Profit Margin 11.77%
EBITDA Margin 20.92%
EBIT Margin 13.01%
FCF Margin 10.36%

Dividends & Yields

This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 4.79%.

Dividend Per Share 1.40
Dividend Yield 4.79%
Dividend Growth (YoY) 7.69%
Years of Dividend Growth 1
Payout Ratio 74.32%
FCF Payout Ratio 84.46%
Buyback Yield 0.39%
Shareholder Yield 5.17%
Earnings Yield 6.43%
FCF Yield 5.67%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on December 16, 2013. It was a reverse split with a ratio of 0.719181284.

Last Split Date Dec 16, 2013
Split Type Reverse
Split Ratio 0.719181284

Scores

Altman Z-Score n/a
Piotroski F-Score 5